| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.1M | -7.4% |
| SG&A Expense | $25.6M | +138.5% |
| Operating Income | -$51.8M | -32.9% |
| Pre-tax Income | -$44.5M | -17.0% |
| Income Tax | $66K | +210.0% |
| Net Income | -$44.6M | -17.4% |
| EPS (Basic) | -$1.22 | +60.8% |
| EPS (Diluted) | -$1.40 | +55.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.3M | +143.5% |
| Current Assets | $24.3M | +132.0% |
| Total Assets | $25.5M | +111.0% |
| Current Liabilities | $9.4M | -27.4% |
| Total Liabilities | $9.8M | -27.1% |
| Stockholders' Equity | $14.3M | +1154.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.6M | -47.0% |
| Capital Expenditures | $104K | -87.9% |
| Investing Cash Flow | -$104K | +87.9% |
| Financing Cash Flow | $61.4M | +167.7% |
| Free Cash Flow | -$47.7M | -43.5% |